PAVmed Inc. (PAVM): Form 8-K filed 2026-11-13
- Accepted by EDGAR
- 2026-11-13 08:05 ET
- Event date
- 2026-11-13
- Accession no.
- 0001493152-26-051544
- Original filing
- SEC EDGAR filing index
AI summary of the filing text. It can contain mistakes; the original filing is authoritative.
PAVmed reports preliminary third quarter results and business updates
PAVmed reported preliminary results for the quarter ended September 30, 2026, with operating expenses of approximately $6.8 million and non-GAAP adjusted net loss of approximately $1.2 million. Lucid began receiving Medicare payments for EsoGuard, while Veris achieved implantable monitor design freeze and initiated a 90-day GLP animal study.
- Operating expenses were approximately $6.8 million for the three months ended September 30, 2026.
- Non-GAAP adjusted net loss was approximately $1.2 million or $(0.19) per common share.
- Cash and cash equivalents were $8.9 million, including restricted cash of $5.3 million, as of September 30, 2026.
- Lucid began receiving Medicare payments for EsoGuard in October.
earningsproductregulatory
Items reported
- Item 2.02: Results of Operations and Financial Condition
The company publicly announced results of operations or financial condition for a completed period, most often a quarterly earnings release. The release itself is usually attached as Exhibit 99.1. Information under Item 2.02 is generally "furnished" rather than "filed". - Item 7.01: Regulation FD Disclosure
The company is making information public under Regulation FD, which requires broad public disclosure of material information shared with certain market participants. Investor presentations and press releases are common. Like Item 2.02, this information is generally "furnished" rather than "filed". - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | form8-k.htm |
| EX-99.1 | EX-99.1 | ex99-1.htm |
The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.